AbbVie Faces Heavy Bearish Options Flow as Put Contracts Flood the $265 Strike

By TrendSpider Editor

The forward setup for ABBV is worth watching closely as November 20 expiration approaches. A move from the current price of $284.98 to the primary $265 strike would represent a decline of roughly two strikes below current levels, implying notable downside risk priced into these contracts. With the s

AbbVie Faces Heavy Bearish Options Flow as Put Contracts Flood the $265 Strike

AbbVie Inc. is drawing significant attention in the options market today, with six unusual put contracts totaling $1,323,470 in premium concentrated heavily at the $265 strike expiring November 20, 2026. Shares are nearly flat on the session, up just 0.09% to $284.98, sitting near the top of their 52-week range of $191.00 to $291.33. The size and concentration of this bearish activity suggests that at least some institutional players are positioning for a meaningful pullback in the weeks ahead.

Key Drivers of the ABBV Stock Move

The forward setup for ABBV is worth watching closely as November 20 expiration approaches. A move from the current price of $284.98 to the primary $265 strike would represent a decline of roughly two strikes below current levels, implying notable downside risk priced into these contracts. With the stock near the high end of its 52-week range between $191.00 and $291.33, any macro or company-specific pressure could accelerate a reversion that would bring these puts into the money. Investors should monitor upcoming AbbVie catalysts, including any pipeline updates or guidance commentary, as the November expiry window captures a period that could include material news flow.

ABBV Unusual Options Activity

All six flagged contracts today are puts, with zero calls among the unusual activity. The breakdown by contract is as follows:

The $265 strike dominates the flow, accounting for five of the six contracts and the overwhelming majority of the total $1,323,470 in premium. The outsized open interest ratios across the board confirm that today's volume is not a routine accumulation but a sharp, concentrated surge relative to existing positioning.

ABBV Seasonality

Late October into November has historically been an active period for large-cap pharmaceutical names, as third-quarter earnings cycles and year-end portfolio rebalancing can drive heightened volatility. The November 20, 2026 expiration window falls within a timeframe that may capture any earnings-related catalysts, making the timing of this put activity particularly relevant for traders tracking seasonal patterns in ABBV.

ABBV Relative Performance

ABBV is trading at $284.98 today, up just 0.09% on the session, placing it near the upper boundary of its 52-week range of $191.00 to $291.33. The stock's proximity to its 52-week high of $291.33 reflects a period of relative outperformance, though today's flat price action suggests momentum may be stalling at current levels, a context that lends additional weight to the bearish options positioning observed in today's session.

More on ABBV

Latest Market News